• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793190
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/23/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The customer complained of false negative results for 1 patient tested for elecsys rubella igg immunoassay (rubella igg) on a cobas 6000 e 601 module.On (b)(6) 2018 the patient was tested for rubella igg on the e601 module and the result was 5.46 iu/ml (negative).This result was reported outside of the laboratory.On (b)(6) 2018 the patient went to another laboratory where a new sample was obtained.The rubella igg result from the immulite technic method as 21 iu/ml (positive) and the result from the diasorin method was 33 iu/ml (positive).On (b)(6) 2018 a new sample was obtained and the rubella igg result from the e601 module was 5.26 iu/ml (negative).This sample was sent to an external laboratory where the result from the diasorin method was 38 iu/ml (positive) and the result from the abbott alinity method was 4 iu/ml (negative).The customer is not sure which results are correct.There was no allegation that an adverse event occurred.The e601 module serial number was (b)(4).The sample from (b)(6) 2018 was submitted for investigation.The rubella igg result at the investigation site was 5.32 iu/ml(negative) which reproduced the customer's result.The rubella igg result seems to be plausible as the rubella igm result at the investigation site was also negative (0.299).A reagent issue was not identified.The investigation is ongoing.
 
Manufacturer Narrative
The sample was investigated further using the platelia rubella igg assay and mikrogen recomblot.The sample tested as weak positive with the platelia rubella igg assay (15.1 iu/ml) and positive with the recomblot method.The patient sample was determined to be positive for rubella igg.A product problem was not found.The assay performed within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7507667
MDR Text Key108374512
Report Number1823260-2018-01450
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04618793190
Device Lot Number28366401
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 04/23/2018
Initial Date FDA Received05/11/2018
Supplement Dates Manufacturer Received04/23/2018
Supplement Dates FDA Received07/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age33 YR
-
-